Home › Companies › Crinetics Pharmaceuticals, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Crinetics Pharmaceuticals, Inc.’s Form 8-K, filed 2026-06-22 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Crinetics Pharmaceuticals, Inc. in the interactive database Compare manager voting policies
These tallies are Crinetics Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-22 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Caren Deardorf | 73,454,076 | -- | -- | 23,532,328 | 5,044,011 | Majority: yes |
| Elect Director: Weston Nichols, Ph.D. | 90,208,564 | -- | -- | 6,777,840 | 5,044,011 | Majority: yes |
| Elect Director: Stephanie S. Okey, M.S. | 72,225,313 | -- | -- | 24,761,091 | 5,044,011 | Majority: yes |
Source: Crinetics Pharmaceuticals, Inc., Form 8-K, filed with the SEC on 2026-06-22 — read the filing on EDGAR.
Each item below shows how the 288 asset managers that disclosed a Crinetics Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Crinetics Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
98% fund support · no official result
The 280 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,323,585 | 0 | 0 | 0 | For |
| Vanguard | 14,742,313 | 9,449 | 7 | 0 | For |
| T. Rowe Price | 12,245,768 | 0 | 0 | 0 | For |
| Wellington | 6,405,153 | 0 | 0 | 0 | For |
| Janus Henderson | 6,320,794 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 5,647,188 | 0 | 0 | 0 | For |
| BlackRock | 5,207,037 | 0 | 275 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,356,345 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,494,448 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 2,198,284 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,859,782 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 1,753,609 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 0 | 1,712,524 | 0 | Abstain |
| Charles Schwab | 1,674,409 | 0 | 0 | 0 | For |
| American Century | 0 | 1,532,768 | 0 | 0 | Against |
| First Light Asset Management, LLC | 1,477,022 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,447,896 | 0 | 0 | 0 | For |
| GW&K Investment Management, LLC | 287,795 | 0 | 0 | 0 | Split |
| Novo Holdings A/S | 1,345,071 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,161,658 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 999,000 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 971,590 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 938,253 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 0 | 892,389 | 0 | Abstain |
| JPMorgan | 873,473 | 0 | 0 | 0 | For |
Showing the 25 largest of 280 asset managers. See all 280 in the interactive database.
Combines 3 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Crinetics Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Caren Deardorf”): 73,454,076 for, 23,532,328 withheld, per its Form 8-K filed 2026-06-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,314,000 outstanding shares: 70% for, 22% withheld (92% of the company cast a for/withheld vote).
The 76 asset managers below cast 100% of the shares they voted on this item FOR (41,526,369 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,889,136 | 0 | 0 | 0 | For |
| Vanguard | 13,888,283 | 0 | 54 | 0 | For |
| T. Rowe Price | 3,737,503 | 0 | 1,242,241 | 0 | For |
| BlackRock | 2,339,620 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 393,885 | 0 | 767,773 | 0 | Abstain |
| Bridge Builder Trust | 34,918 | 0 | 936,672 | 0 | Abstain |
| JPMorgan | 847,277 | 0 | 0 | 0 | For |
| Charles Schwab | 836,954 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 759,548 | 0 | Abstain |
| Columbia Threadneedle | 741,714 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 722,721 | 0 | Abstain |
| Prudential/PGIM | 357,533 | 0 | 98,165 | 0 | For |
| Hartford | 367,623 | 0 | 0 | 0 | For |
| TIAA | 356,595 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 350,000 | 0 | 0 | 0 | For |
| AMG FUNDS | 255,812 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 244,313 | 0 | Abstain |
| Equitable | 156,356 | 0 | 75,390 | 0 | For |
| Victory Capital | 754 | 0 | 226,114 | 0 | Abstain |
| Voya | 0 | 0 | 201,990 | 0 | Abstain |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 0 | 170,496 | 0 | Abstain |
| John Hancock | 73,540 | 0 | 55,795 | 0 | For |
| Dimensional | 0 | 0 | 128,939 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 119,242 | 0 | Abstain |
| Brinker Capital Destinations Trust | 2,311 | 0 | 103,846 | 0 | Abstain |
Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.
Combines 3 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Crinetics Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Stephanie S. Okey, M.S.”): 72,225,313 for, 24,761,091 withheld, per its Form 8-K filed 2026-06-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,314,000 outstanding shares: 69% for, 24% withheld (92% of the company cast a for/withheld vote).
The 76 asset managers below cast 100% of the shares they voted on this item FOR (41,466,576 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,889,136 | 0 | 0 | 0 | For |
| Vanguard | 13,882,688 | 0 | 5,650 | 0 | For |
| T. Rowe Price | 3,737,503 | 0 | 1,242,241 | 0 | For |
| BlackRock | 2,339,620 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 393,885 | 0 | 767,773 | 0 | Abstain |
| Bridge Builder Trust | 34,918 | 0 | 936,672 | 0 | Abstain |
| JPMorgan | 847,277 | 0 | 0 | 0 | For |
| Charles Schwab | 836,954 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 759,548 | 0 | Abstain |
| Columbia Threadneedle | 741,714 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 722,721 | 0 | Abstain |
| Prudential/PGIM | 357,533 | 0 | 98,165 | 0 | For |
| Hartford | 367,623 | 0 | 0 | 0 | For |
| TIAA | 356,595 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 350,000 | 0 | 0 | 0 | For |
| AMG FUNDS | 255,812 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 244,313 | 0 | Abstain |
| Equitable | 156,356 | 0 | 75,390 | 0 | For |
| Victory Capital | 754 | 0 | 226,114 | 0 | Abstain |
| Voya | 0 | 0 | 201,990 | 0 | Abstain |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 0 | 170,496 | 0 | Abstain |
| John Hancock | 73,540 | 0 | 55,795 | 0 | For |
| Dimensional | 0 | 0 | 128,939 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 119,242 | 0 | Abstain |
| Brinker Capital Destinations Trust | 2,311 | 0 | 103,846 | 0 | Abstain |
Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Crinetics Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Weston Nichols, Ph.D.”): 90,208,564 for, 6,777,840 withheld, per its Form 8-K filed 2026-06-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,314,000 outstanding shares: 86% for, 6% withheld (92% of the company cast a for/withheld vote).
The 76 asset managers below cast 100% of the shares they voted on this item FOR (47,506,873 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,889,136 | 0 | 0 | 0 | For |
| Vanguard | 13,888,320 | 0 | 17 | 0 | For |
| T. Rowe Price | 4,979,744 | 0 | 0 | 0 | For |
| BlackRock | 2,339,620 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,161,658 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 971,590 | 0 | 0 | 0 | For |
| JPMorgan | 847,277 | 0 | 0 | 0 | For |
| Charles Schwab | 836,954 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 759,548 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 741,714 | 0 | 0 | 0 | For |
| American Century | 722,721 | 0 | 0 | 0 | For |
| Prudential/PGIM | 452,600 | 0 | 3,098 | 0 | For |
| Hartford | 367,623 | 0 | 0 | 0 | For |
| TIAA | 356,595 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 350,000 | 0 | 0 | 0 | For |
| AMG FUNDS | 255,812 | 0 | 0 | 0 | For |
| Jackson National | 227,977 | 0 | 16,336 | 0 | For |
| Equitable | 156,356 | 0 | 75,390 | 0 | For |
| Victory Capital | 226,868 | 0 | 0 | 0 | For |
| Voya | 201,990 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 170,496 | 0 | 0 | 0 | For |
| John Hancock | 98,269 | 0 | 31,066 | 0 | For |
| Dimensional | 0 | 0 | 128,939 | 0 | Abstain |
| AIG/SunAmerica | 119,242 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 106,157 | 0 | 0 | 0 | For |
Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.9% fund support · no official result
The 75 asset managers below cast 99.9% of the shares they voted on this item FOR (47,762,727 for, 1 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,889,136 | 0 | 0 | 0 | For |
| Vanguard | 13,888,336 | 1 | 0 | 0 | For |
| T. Rowe Price | 4,979,744 | 0 | 0 | 0 | For |
| BlackRock | 2,339,620 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,161,658 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 971,590 | 0 | 0 | 0 | For |
| JPMorgan | 847,277 | 0 | 0 | 0 | For |
| Charles Schwab | 836,954 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 759,548 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 741,714 | 0 | 0 | 0 | For |
| American Century | 722,721 | 0 | 0 | 0 | For |
| Prudential/PGIM | 455,698 | 0 | 0 | 0 | For |
| Hartford | 367,623 | 0 | 0 | 0 | For |
| TIAA | 356,595 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 350,000 | 0 | 0 | 0 | For |
| AMG FUNDS | 255,812 | 0 | 0 | 0 | For |
| Jackson National | 244,313 | 0 | 0 | 0 | For |
| Equitable | 231,746 | 0 | 0 | 0 | For |
| Victory Capital | 226,868 | 0 | 0 | 0 | For |
| Voya | 201,990 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 170,496 | 0 | 0 | 0 | For |
| John Hancock | 129,335 | 0 | 0 | 0 | For |
| Dimensional | 128,939 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 119,242 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 106,157 | 0 | 0 | 0 | For |
Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (84,917 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SECTOR GAMMA AS | 74,446 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 10,321 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 150 | 0 | 0 | 0 | For |
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (26 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 26 | 0 | 0 | 0 | For |
| Ikarian Capital, LLC | 0 | 0 | 0 | 0 | -- |
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (323,361 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fiera Capital Corp | 323,361 | 0 | 0 | 0 | For |
| National Philanthropic Trust | 0 | 0 | 0 | 0 | Not Voted |
Ranked by the number of Crinetics Pharmaceuticals, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 105,314,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 29.74% |
| 2 | Vanguard | 14.01% |
| 3 | T. Rowe Price | 11.63% |
| 4 | Wellington | 6.08% |
| 5 | Janus Henderson | 6.00% |
| 6 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.36% |
| 7 | BlackRock | 4.94% |
| 8 | DRIEHAUS CAPITAL MANAGEMENT LLC | 4.14% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.37% |
| 10 | Polar Capital Holdings Plc | 2.09% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 14.96% | 13F |
| FMR LLC | 13.25% | DEF14A |
| Vanguard Group | 8.67% | 13F |
| Farallon Capital Management, L.L.C. | 8.54% | 13G |
| BlackRock | 8.05% | 13F |
| Wellington Management | 7.75% | 13F |
| Farallon Capital Partners, L.P. | 7.62% | DEF14A |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6.07% | 13G |
| T. Rowe Price | 5.09% | 13F |
| R. Scott Struthers, Ph.D. | 2.45% | DEF14A |
Percentages above are of 105,314,000 shares outstanding, as reported by Crinetics Pharmaceuticals, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Crinetics Pharmaceuticals, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Crinetics Pharmaceuticals, Inc.'s shareholder meeting held 2026-06-18, in the 2025-2026 proxy season, 288 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,876 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Crinetics Pharmaceuticals, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — the reporting funds cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
Crinetics Pharmaceuticals, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).